CLOVIS ONCOLOGY, INC. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/77906d8c-1d2d-41d3-99f0-9100194ff3f9/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-264.5M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-001810 |
| FY 2020 | $-369.2M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001668 |
| FY 2019 | $-400.4M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001500 |
| FY 2018 | $-368.0M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001212 |
| FY 2017 | $-346.4M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001172 |
| FY 2016 | $-349.1M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-000902 |
| FY 2015 | $-352.9M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013672 |
| FY 2014 | $-160.0M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001099 |
| FY 2013 | $-269.0M | 2009-04-20 – 2013-12-31 | evidence 0001193125-14-076654 |
| FY 2012 | $-200.2M | 2009-04-20 – 2013-03-31 | evidence 0001193125-13-206789 |
| FY 2011 | $-129.5M | 2009-04-20 – 2012-03-31 | evidence 0001193125-12-227760 |
| FY 2010 | $-37.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-106580 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CLOVIS ONCOLOGY, INC. — all facts · Revenue · Operating Income